https://www.selleckchem.com/pr....oducts/Isradipine(Dy
ger imaging follow-up may be needed before initiating salvage in those without symptomatic progression. Several tumor and dosimetric predictors have been suggested for the development of different toxicities, requiring further evaluation. Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). A retrospective review was conducted on all patients who were treated with IMPT for HCC with curative intent from June 2015 to December 2018.
Me gusta
Comentario
Compartir
